Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$10.53 -0.73 (-6.48%)
As of: Oct 2, 2026 · 2:08 PM EDT

Monte Rosa Therapeutics (GLUE) Shares Outstanding (Diluted) (2021 - 2026)

Updated

Monte Rosa Therapeutics' Shares Outstanding (Diluted) came in at 101.48 million for Q2 2026, up 23.5% from 82.19 million a year earlier and up 1.6% from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

For FY2025, Monte Rosa Therapeutics' Shares Outstanding (Diluted) was 83.07 million, up 12.4% from FY2024.

  • Shares Outstanding (Diluted) has increased in each of the last four years, with a four-year compound annual growth rate of 35.0% (FY2021 to FY2025).
  • Going back by year, Shares Outstanding (Diluted) was 73.91 million in FY2024 (+43.8%), 51.4 million in FY2023 (+8.8%), 47.23 million in FY2022 (+88.9%) and 25 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2021.
  • Year-over-year, Shares Outstanding (Diluted) has increased for 17 consecutive quarters, with growth averaging 27.3% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.5% in Q3 2025 to 820.4% in Q2 2022.
  • Business Quant data shows GLUE's Shares Outstanding (Diluted) at 99.88 million (Q1 2026), 83.07 million (Q4 2025) and 82.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Monte Rosa Therapeutics 1.02 Bn 428.56 Mn - 101.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 101.48 Mn
Mar 31, 2026 99.88 Mn
Dec 31, 2025 83.07 Mn
Sep 30, 2025 82.40 Mn
Jun 30, 2025 82.19 Mn
Mar 31, 2025 82.96 Mn
Dec 31, 2024 73.91 Mn
Sep 30, 2024 82.01 Mn
Jun 30, 2024 71.23 Mn
Mar 31, 2024 60.16 Mn
Dec 31, 2023 51.40 Mn
Sep 30, 2023 49.81 Mn
Jun 30, 2023 49.43 Mn
Mar 31, 2023 49.35 Mn
Dec 31, 2022 47.23 Mn
Sep 30, 2022 46.73 Mn
Jun 30, 2022 46.67 Mn
Mar 31, 2022 46.60 Mn
Dec 31, 2021 25.00 Mn
Sep 30, 2021 45.99 Mn
API Access

Monte Rosa Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GLUE&period=max&api_key=YOUR_API_KEY